Paragraph 9 Additional requirements in relation to electronic prescribing
United Kingdom
The LPS contractor (C) must, if requested to do so by any person—
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
where the Electronic Prescription Service is F2temporarily unavailable through C's scheme premises, provide that person with contact details of at least two pharmacies in the area through which the service is available, if these details are known to C.
F3... C must, if requested to do so by any person, enter in that person's PDS patient details—
where the person does not have a nominated dispensing contractor, F4a nominated dispensing contractor; or
where the person does have a nominated dispensing contractor—
a replacement dispensing contractor, or
a further dispensing contractor,
chosen by that person.
Sub-paragraph (2)(b)(ii) does not apply if the number of nominated dispensing contractors for that person would thereby exceed the maximum number permitted by the Electronic Prescription Service.
If C is a nominated dispensing contractor for a person (X) but the nomination was made before C became the person specified in an LPS scheme in relation to the scheme premises nominated in X's PDS patient details, C must within 6 months of C becoming the person so specified—
explain to X that the ownership of the scheme premises has changed; and
ask X whether X wishes to maintain the nomination in respect of those scheme premises.
If C dispenses an electronic prescription or makes an urgent supply without a prescription, C must send the form duly completed by or on behalf of the patient, if one is required under regulation 3(3)(b) or (c), (5C) or (5E) of the Charges Regulations in respect of that prescription (which may be the associated EPS token), to the NHS BSA.
C must not enter a dispensing contractor into, or change a dispensing contractor in, a person’s PDS patient details without that person’s, or a duly authorised person representing that person’s, explicit consent.
Annotations
Textual amendments
- F1
Sch. 7 para. 9(1)(a) omitted (9.11.2020) by virtue of The National Health Service (Charges and Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2020 (S.I. 2020/1126), regs. 1(2), 26(a)(i)
- F2
Words in Sch. 7 para. 9(1)(b) substituted (9.11.2020) by The National Health Service (Charges and Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2020 (S.I. 2020/1126), regs. 1(2), 26(a)(ii)
- F3
Words in Sch. 7 para. 9(2) omitted (9.11.2020) by virtue of The National Health Service (Charges and Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2020 (S.I. 2020/1126), regs. 1(2), 26(b)
- F4
Words in Sch. 7 para. 9(2)(a) substituted (26.11.2018) by The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2018 (S.I. 2018/1114), regs. 1(1), 10(5)(a)
- F5
Sch. 7 para. 9(5) inserted (26.11.2018) by The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2018 (S.I. 2018/1114), regs. 1(1), 10(5)(b)
- F6
Sch. 7 para. 9(6) inserted (1.10.2026) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2026 (S.I. 2026/961), regs. 1(2), 11(2)